Tag: NASDAQ

Posted on

Article: Farmmi Receives NASDAQ Minimum Bid Price Requirement Extension

Article - Media, Publications

Farmmi Receives NASDAQ Minimum Bid Price Requirement Extension

PRNewswire, 20 October 2020

Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI), an agriculture products supplier in China, today announced that on October 19, 2020, it received notification from The Nasdaq Stock Market LLC (“NASDAQ”) confirming the Company has been granted an additional 180 calendar day period for compliance under its minimum bid price requirement through April 13, 2021. To regain compliance with NASDAQ’s minimum bid price requirement, the closing bid price of the Company’s ordinary shares needs to be at least $1.00 per share or greater for at least ten consecutive business days by April 13, 2021.

Read Full Article

Posted on

Article: China Ceramics Announces Corporate Name Change to Antelope Enterprise Holdings Limited

Article - Media, Publications

China Ceramics Announces Corporate Name Change to Antelope Enterprise Holdings Limited”

PRNewswire, 14 October 2020

JINJIANG, Fujian Province, China, Oct. 14, 2020 /PRNewswire/ — China Ceramics Co., Ltd. (NASDAQ Capital Market: CCCL) (“China Ceramics” or the “Company”), a diversified company that manufactures ceramic tiles used in residential and commercial buildings, and engages in computer consulting and software development in China, today announced its name change to Antelope Enterprise Holdings Limited (“Antelope”). With the corporate name change, beginning on October 15, 2020, the Company’s shares will continue trading on the Nasdaq Stock Market under a new ticker symbol “AEHL”; the new CUSIP number associated with the name change is G041JN106. Continue reading “Article: China Ceramics Announces Corporate Name Change to Antelope Enterprise Holdings Limited”

Posted on

Article: Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud

Article - Media, Publications

Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud

PRNewswire, 18 September 2020

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX). A complaint has been filed on behalf of investors who purchased the publicly traded securities of Nano-X between August 21, 2020 and September 15, 2020, inclusive (the “Class Period”).

According to the complaint, Nano-X’s securities began trading on the NASDAQ on August 21, 2020. Continue reading “Article: Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud”

Posted on

Article: Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study

Article - Media, Publications

Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study

PRNewswire, 08 July 2020

Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference (“ddRNAi”) platform, today announced the initiation of the BB-301 Tissue Transduction Study in large animal subjects. Continue reading “Article: Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study”

Posted on

Article: Form S-1/A Jupiter Wellness, Inc.

Article - Media, Publications

Form S-1/A Jupiter Wellness, Inc.

BONGIOVANNI MICHAEL J, 04 July 2020

We are offering 1,000,000 units (each, a “Unit”), each Unit consisting of one share of common stock, par value $0.001 per share, and one warrant (each a “Warrant”), in a firm commitment initial public offering at an assumed price of US$7.50 per Unit. Each Warrant is immediately exercisable, will entitle the holder to purchase one share of common stock at an exercise price of US$8.50 and will expire five (5) years from the date of issuance. The shares of common stock and Warrants may be transferred separately immediately upon issuance.

We intend to apply to list our shares of common stock and Warrants for trading on the Nasdaq Capital Market, subject to official notice of issuance, under the symbols “JUPW” and “JUPWW”. Completion of this offering is contingent on the approval of our listing application for trading on the Nasdaq Market.

We are an emerging growth company under the Jumpstart our Business Startups Act of 2012, or JOBS Act, and, as such, may elect to comply with certain reduced public company reporting requirements for future filings. Investing in our securities involves a high degree of risk.

Read Full Article

Posted on

Article: Coffee’s for Closers: How a Short Seller’s Warning Helped Take Down Luckin Coffee

Article - Media, Publications

Coffee’s for Closers: How a Short Seller’s Warning Helped Take Down Luckin Coffee

Jing Yang in Hong Kong, Juliet Chung in New York and Julie Steinberg in London, 23 June 2020

In January, days after the shares of Luckin Coffee Inc. hit a record high on the Nasdaq Stock Market , giving the company a $12 billion valuation, a cryptic email arrived in the inboxes of multiple short sellers. “A new generation of Chinese Fraud 2.0 has emerged,” it said. “Companies that start off as fundamentally and structurally flawed business model [sic] that evolves into fraud.” The author offered to share customer receipts and videos from Luckin Coffee outlets, attached a long report about the company and said the short sellers could publish and take credit for it. Continue reading “Article: Coffee’s for Closers: How a Short Seller’s Warning Helped Take Down Luckin Coffee”

Posted on

Article: Why You Should Care About Mercurity Fintech Holding Inc.’s (NASDAQ:MFH) Low Return On Capital

Article - Media, Publications

Why You Should Care About Mercurity Fintech Holding Inc.’s (NASDAQ:MFH) Low Return On Capital

Simply Wall St, 14 June 2020

Today we’ll look at Mercurity Fintech Holding Inc. (NASDAQ:MFH) and reflect on its potential as an investment. Specifically, we’ll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires.

First, we’ll go over how we calculate ROCE. Second, we’ll look at its ROCE compared to similar companies. Finally, we’ll look at how its current liabilities affect its ROCE. Continue reading “Article: Why You Should Care About Mercurity Fintech Holding Inc.’s (NASDAQ:MFH) Low Return On Capital”

Posted on

Article: Were Hedge Funds Right About InMode Ltd (INMD)

Article - Media, Publications

Were Hedge Funds Right About InMode Ltd (INMD)/strong>

Debasis Saha, 06 May 2020

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy long-term Treasury bonds. Our article also called for a total international travel ban. While we were warning you, President Trump minimized the threat and failed to act promptly. As a result of his inaction, we will now experience a deeper recession (see why hell is coming). Continue reading “Article: Were Hedge Funds Right About InMode Ltd (INMD)”

Posted on

Article: Should You Be Concerned About Benitec Biopharma Limited’s (NASDAQ:BNTC) Historical Volatility?

Article - Media, Publications

Should You Be Concerned About Benitec Biopharma Limited’s (NASDAQ:BNTC) Historical Volatility?

Simply Wall St, 20 April 2020

Anyone researching Benitec Biopharma Limited (NASDAQ:BNTC) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caused by the natural volatility of markets, overall. For example, certain macroeconomic events will impact (virtually) all stocks on the market. Continue reading “Article: Should You Be Concerned About Benitec Biopharma Limited’s (NASDAQ:BNTC) Historical Volatility?”

Posted on

Article: FINRA, Exchanges Blast Credit Suisse Over Failure to Prevent Market Manipulation

Article - Media, Publications

FINRA, Exchanges Blast Credit Suisse Over Failure to Prevent Market Manipulation

Jeff Berman, 23 December 2019

The Financial Industry Regulatory Authority, Nasdaq, the New York Stock Exchange and Cboe Global Markets all censured Credit Suisse Securities and fined the firm $6.5 million for supervisory and Securities Exchange Act of 1934/Market Access Rule violations after repeated failures to prevent market manipulation, FINRA said Monday.

Credit Suisse signed a letter of acceptance, waiver and consent on Nov. 18 in which it agreed to the censure and $6.5 million fine, of which $566,583 is to be paid to FINRA for violating multiple rules. FINRA accepted the letter Nov. 19.

A Credit Suisse spokesman on Monday said only that the firm was “pleased to have resolved these matters with FINRA and these exchanges.” Continue reading “Article: FINRA, Exchanges Blast Credit Suisse Over Failure to Prevent Market Manipulation”

Posted on

Article: Form S-1/A Bionano Genomics, Inc

Article - Media, Publications

Form S-1/A Bionano Genomics, Inc

EDGARFILINGS LTD, 17 October 2020

We are offering 5,265,000 shares of our common stock and common warrants to purchase an aggregate of 5,265,000 shares of our common stock (and the shares of common stock that are issuable from time to time upon exercise of the warrants). We are also offering to certain purchasers whose purchase of shares of common stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock immediately following the consummation of this offering, the opportunity to purchase, if any such purchaser so chooses, pre-funded warrants, in lieu of shares of common stock that would otherwise result in such purchaser’s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock. Each pre-funded warrant will be exercisable for one share of our common stock. Continue reading “Article: Form S-1/A Bionano Genomics, Inc”

Posted on

Article: Why Rewalk Robotics (RWLK) Stock Is Skyrocketing Today

Article - Media, Publications

Why Rewalk Robotics (RWLK) Stock Is Skyrocketing Today

Karl Utermohlen, 20 July 2018

Rewalk Robotics (NASDAQ:RWLK) had a good day as the company’s stock was skyrocketing following a revision to the company’s national policies from the U.S. Department of Veterans Affairs (VA)

The Israel-based company said that the aforementioned agency issued a revision to the company’s national policy regarding its exoskeleton medical device training and procurement for qualifying Veterans with spinal cord injury (SCI). The new policy includes additional guidance throughout the evaluation process of this treatment.

Plus, the announcement also means that more veterans will have access to Rewalk Robotics training program locations across the VA network, as well as expanded access to private rehabilitation centers through the company’s Veterans Choice Program

Read Full Article

Posted on

Article: PURE MARKET MANIPULATION CLAIMS REMAIN OUT OF REACH FOR SOME SHAREHOLDERS VICTIMIZED BY MYSTERIOUS STOCK PRICE REVERSALS

Article - Media, Publications

PURE MARKET MANIPULATION CLAIMS REMAIN OUT OF REACH FOR SOME SHAREHOLDERS VICTIMIZED BY MYSTERIOUS STOCK PRICE REVERSALS

Emergent Law,  31 October 2017

Wins Finance Holdings Inc. (“Wins”), a company that guarantees loans and leases equipment for small businesses in China, has been the target of multiple securities class action lawsuits ever since the news broke in March of this year that it was under investigation by the SEC for market manipulation of its stock. Incredibly, the stock price of Wins soared over 4,000% since the inception of trading near the end of 2015, with no company news headlines to explain this market bubble. On March 30, 2017, the investment analytics site Seeking Alpha reported the SEC investigation and the fact that Wins had mislead the Russell Index into including the company based upon a false report of the location of its headquarters.

On this news, the stock price plunged back to levels below $50 per share, only to be followed by another mysterious spike up to the $200 level in the early summer of this year. On June 7, 2017, NASDAQ announced that it was halting trade in Wins stock pending the receipt of further information from the company. On August 4, 2017, NASDAQ sent Wins a delisting determination letter, but withdrew this letter on October 19, 2017. The stock remains halted while NASDAQ awaits further information from Wins. Continue reading “Article: PURE MARKET MANIPULATION CLAIMS REMAIN OUT OF REACH FOR SOME SHAREHOLDERS VICTIMIZED BY MYSTERIOUS STOCK PRICE REVERSALS”

Posted on

Article: Supreme Court Decides Merrill Lynch, Pierce, Fenner & Smith Inc. v. Manning

Article - Media, Publications

Supreme Court Decides Merrill Lynch, Pierce, Fenner & Smith Inc. v. Manning

Chuck Webber, Jeffrey P. Justman, James G. Martignon, 05 May 2016

On May 16, 2016, the Supreme Court of the United States decided Merrill Lynch, Pierce, Fenner & Smith Inc. v. Manning, No. 14-1132, holding that that the “arising under” test for federal-question jurisdiction under 28 U.S.C. § 1331 determines whether federal courts have exclusive jurisdiction under section 27 of the Securities Exchange Act of 1934 (the “Exchange Act”) of lawsuits to enforce liabilities or duties created by that Act. (The Court did not address the portion of section 27 that gives federal courts exclusive jurisdiction of “violations of this chapter or the rules and regulations thereunder” with respect to criminal and regulatory enforcement actions.)

Greg Manning owned stock in Escala Group, Inc., a company traded on the NASDAQ. Between 2006 and 2007, Escala’s share price plummeted and Manning lost most of his investment. Manning blamed Merrill Lynch and other financial institutions for devaluing Escala during that period through “naked short sales” of its stock, under which one borrows stock from a broker and sells it to a buyer on the open market, but never delivers the shares back to the buyer. “Naked” short sales of stock may be designed to drive down a company’s stock price, and are accordingly regulated by Regulation SHO. Continue reading “Article: Supreme Court Decides Merrill Lynch, Pierce, Fenner & Smith Inc. v. Manning”

Posted on

Article: Benitec: The Health Payer’s Dream Biotech

Article - Media, Publications

Benitec: The Health Payer’s Dream Biotech

Pannobhaso, 12 March 2014

When it comes to forecasting the size of the market for drugs to treat various diseases, the estimates for the same disease can seem to fluctuated wildly depending on the model used and the timeframe of the forecast. However, one thing that is fairly consistent is that for many of the major diseases, these forecasts involve big numbers – billions of dollars. However, as a guide to pharmaceutical earnings, these forecasts are meaningless if health payers cannot afford the costs. Continue reading “Article: Benitec: The Health Payer’s Dream Biotech”

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?